Clinical Trial Update: ChiCGB vs BEAM in High-risk or R/R Lymphomas [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing ChiCGB to BEAM in high-risk or refractory/relapsed lymphomas is listed with phase 3 and unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• T-cell Lymphoma

Drugs mentioned

• BEAM
• ChiCGB

Snippet

Sponsor: Sichuan University | Conditions: Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell | Phase 3 | Status: UNKNOWN